0.2806
price down icon4.13%   -0.0121
after-market 시간 외 거래: .27 -0.0106 -3.78%
loading
전일 마감가:
$0.2927
열려 있는:
$0.28
하루 거래량:
682.35K
Relative Volume:
1.83
시가총액:
$11.59M
수익:
$7.10M
순이익/손실:
$-39.43M
주가수익비율:
-0.2985
EPS:
-0.94
순현금흐름:
$-46.50M
1주 성능:
-4.91%
1개월 성능:
-21.47%
6개월 성능:
-38.45%
1년 성능:
-66.57%
1일 변동 폭
Value
$0.27
$0.31
1주일 범위
Value
$0.26
$0.31
52주 변동 폭
Value
$0.26
$0.87

스프루스 바이오 Stock (SPRB) Company Profile

Name
명칭
Spruce Biosciences Inc
Name
전화
(415) 655-4168
Name
주소
611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO
Name
직원
22
Name
트위터
Name
다음 수익 날짜
2025-03-31
Name
최신 SEC 제출 서류
Name
SPRB's Discussions on Twitter

SPRB을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
SPRB
Spruce Biosciences Inc
0.2806 11.59M 7.10M -39.43M -46.50M -0.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

스프루스 바이오 Stock (SPRB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-11 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2024-12-11 다운그레이드 Oppenheimer Outperform → Perform
2024-03-14 다운그레이드 Guggenheim Buy → Neutral
2024-03-14 다운그레이드 H.C. Wainwright Buy → Neutral
2024-03-14 다운그레이드 Ladenburg Thalmann Buy → Neutral
2024-03-14 다운그레이드 Leerink Partners Outperform → Market Perform
2024-03-14 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2024-02-21 개시 Guggenheim Buy
2021-12-17 개시 Oppenheimer Outperform
2021-12-10 개시 The Benchmark Company Speculative Buy
2021-11-16 다운그레이드 SVB Leerink Outperform → Mkt Perform
2021-07-19 개시 H.C. Wainwright Buy
2021-04-26 재개 Credit Suisse Outperform
2020-11-03 개시 Cowen Outperform
2020-11-03 개시 Credit Suisse Outperform
2020-11-03 개시 RBC Capital Mkts Outperform
2020-11-03 개시 SVB Leerink Outperform
모두보기

스프루스 바이오 주식(SPRB)의 최신 뉴스

pulisher
11:31 AM

Layoff Tracker: Relay Will Cut 70 Employees, Affecting Research Budget by 75% - BioSpace

11:31 AM
pulisher
Apr 01, 2025

Spruce Biosciences reports delayed annual filing By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Spruce Biosciences reports delayed annual filing - Investing.com

Apr 01, 2025
pulisher
Mar 31, 2025

Spruce Biosciences Delays Annual Report Filing - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Mar 31, 2025
pulisher
Mar 25, 2025

Spruce Biosciences stock hits 52-week low at $0.32 - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

In-Depth Analysis Of The Global Congenital Adrenal Hyperplasia Market: Key Drivers, Trends, Growth Opportun... - WhaTech

Mar 25, 2025
pulisher
Mar 22, 2025

SPRUCE BIOSCIENCES INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com

Mar 22, 2025
pulisher
Mar 20, 2025

Invivyd, Inc. (IVVD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 20, 2025
pulisher
Mar 14, 2025

Analysts Set Spruce Biosciences, Inc. (NASDAQ:SPRB) PT at $2.38 - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

SPRB Stock Touches 52-Week Low at $0.34 Amid Steep Decline - Investing.com India

Mar 12, 2025
pulisher
Mar 11, 2025

Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 11, 2025
pulisher
Mar 05, 2025

Spruce Biosciences (SPRB) to Release Quarterly Earnings on Wednesday - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Harbour Biomed newco HBM Alpha pens $395M hyperplasia drug deal - BioWorld Online

Mar 04, 2025
pulisher
Mar 04, 2025

SPRB stock touches 52-week low at $0.34 amid sharp annual decline - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Short Interest in Kingsoft Co. Limited (OTCMKTS:KSFTF) Increases By 79.4% - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Archer-Daniels-Midland Company (NYSE:ADM) Receives Consensus Rating of “Reduce” from Brokerages - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Traws Pharma, Inc. (NASDAQ:TRAW) Short Interest Update - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Spruce Biosciences, Inc. (NASDAQ:SPRB) Short Interest Up 81.4% in February - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

SPRB stock touches 52-week low at $0.34 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Feb 28, 2025

Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 21, 2025

Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates - MSN

Feb 21, 2025
pulisher
Feb 18, 2025

NeoGenomics (NEO) Tops Q4 Earnings Estimates - Yahoo Finance

Feb 18, 2025
pulisher
Feb 17, 2025

The Prothena Corporation plc (PRTA) had a good session last reading, didn’t it? - US Post News

Feb 17, 2025
pulisher
Feb 17, 2025

Element Solutions Inc (NYSE:ESI) Receives $30.14 Consensus Price Target from Analysts - Defense World

Feb 17, 2025
pulisher
Feb 17, 2025

Alamos Gold Inc. (TSE:AGI) Receives C$28.78 Average Target Price from Brokerages - Defense World

Feb 17, 2025
pulisher
Feb 17, 2025

Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives $3.90 Consensus Target Price from Analysts - Defense World

Feb 17, 2025
pulisher
Feb 10, 2025

Spruce Biosciences Inc [SPRB] Investment Appeal on the Rise - Knox Daily

Feb 10, 2025
pulisher
Feb 08, 2025

Spruce Biosciences Inc (NASDAQ: SPRB) Stock Has Gained 4.05% Over The Month – Is There Room For Growth? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

Should You Expect Akero Therapeutics Inc (NASDAQ:AKRO) To Recover From Its 70.02% Gain From Highs? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

Five Point Holdings LLC (NYSE: FPH): Can The Stock Still Lose Despite An 54.23% YTD Gain? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 07, 2025

Why you might not want to use AI to spruce up your job application - Yahoo

Feb 07, 2025
pulisher
Feb 04, 2025

Spruce Biosciences Inc (SPRB) Stock Price and Analyst Predictions - The News Heater

Feb 04, 2025
pulisher
Feb 04, 2025

Spruce Biosciences Inc (NASDAQ:SPRB) stock: You might be surprised - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Examining OppFi Inc (OPFI) stock is warranted - US Post News

Feb 04, 2025
pulisher
Jan 27, 2025

(PDF) Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials - ResearchGate

Jan 27, 2025
pulisher
Jan 23, 2025

Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives $3.90 Consensus Target Price from Brokerages - Defense World

Jan 23, 2025

스프루스 바이오 (SPRB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

스프루스 바이오 주식 (SPRB) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Charlton Ralph William III
CHIEF MEDICAL OFFICER
Dec 10 '24
Option Exercise
0.00
106,400
0
161,773
Gharib Samir M.
PRESIDENT AND CFO
Dec 16 '24
Option Exercise
0.00
75,750
0
363,841
Gharib Samir M.
PRESIDENT AND CFO
Dec 10 '24
Option Exercise
0.00
154,000
0
356,776
Szwarcberg Javier B.
CHIEF EXECUTIVE OFFICER
Dec 16 '24
Option Exercise
0.00
200,700
0
506,796
Szwarcberg Javier B.
CHIEF EXECUTIVE OFFICER
Dec 10 '24
Option Exercise
0.00
358,800
0
466,121
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):